Jump to main content
Jump to site search


Pharmaceutical cocrystals of naringenin with improved dissolution performance

Author affiliations

Abstract

Naringenin (NAR), a natural flavanone compound, has received increasing attention in recent years due to its diverse pharmacological activities. However, this bioflavonoid shows poor solubility and therefore is difficult to absorb on oral ingestion. To improve the solubility of NAR, co-crystallization trials were performed, and four NAR cocrystals were obtained for the first time. All products were comprehensively characterized by a range of analytical methods, including single crystal and powder X-ray diffraction (XRD), liquid and solid state nuclear magnetic resonance (NMR), Fourier transform infrared spectroscopy (FTIR), and differential scanning calorimetry (DSC). The dissolution studies revealed that all the four cocrystals, namely, NAR–isonicotinamide (NAR–INM), NAR–picolinic acid (NAR–PCA), and two modifications of NAR–betaine (NAR–BTN), exhibit improved apparent solubilities and intrinsic dissolution rates (IDRs) relative to the parent NAR. Two NAR–BTN forms are monotropically related. Additionally, BTN was used for the first time to form cocrystals with flavonoid compounds, which may provide crystallographic inspiration for the cocrystal design and screening of these kinds of bioactive molecules.

Graphical abstract: Pharmaceutical cocrystals of naringenin with improved dissolution performance

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Mar 2018, accepted on 20 Apr 2018 and first published on 20 Apr 2018


Article type: Paper
DOI: 10.1039/C8CE00341F
Citation: CrystEngComm, 2018, Advance Article
  •   Request permissions

    Pharmaceutical cocrystals of naringenin with improved dissolution performance

    C. Luo, W. Liang, X. Chen, J. Wang, Z. Deng and H. Zhang, CrystEngComm, 2018, Advance Article , DOI: 10.1039/C8CE00341F

Search articles by author

Spotlight

Advertisements